As shown in Figure 2, we found that TNBC patients had significantly higher levels of ANXA1 mRNA expression compared to the other subtypes of breast cancer patients in both cohorts; TCGA, which is mainly United States patients, and Molecular Taxonomy of Breast Cancer International Consortium (METABRIC), which is mainly United Kingdom and Canada patients (p < 0.001, respectively). The gene discussed is ANXA1; the disease is breast carcinoma.